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A Diagnostic Assessment of the Health System’s
Response to FGM/C Management and Prevention
in Nigeria
Findings from this study show that the level of readiness of the health
facilities to handle FGM/C-related complications is low as evidenced by poor
infrastructure, lack of equipment and limited human capacity.
Improving the health system response in the prevention and management
of FGM/C complications requires focused funding, political leadership and
better stakeholder coordination.
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Female genital mutilation (FGM/C), has no health benefits, it violates human rights and
has adverse health (physical, psychological, sexual, maternal and child health), and
social consequences 1, 2. Globally, over 200 million women have been cut and are living
with FGM/C-related consequences 3, 4. In Africa, it is estimated that 27 million, 24 million
and 20 million girls/women have undergone FGM/C in Egypt, Ethiopia and Nigeria
respectively, making them the countries with the highest prevalence of FGM/C on the
continent 5. In Nigeria, although the practice is considered widespread, national surveys
suggest a gradual decline of FGM/C prevalence among women aged 15 – 49 years
30% in 2008 to 20% in 2018 6,7. While these statistics suggest progress, the prevalence
is, however, is still as high as 67% in some states8. Despite the existence of laws,
policies and a plan of action that should drive the health system’s response to
prevention and management of FGM/C, the practice persists. Nigeria’s National
Strategic Health Development Plan Framework (2009- 2015) highlighted the need to
strengthen the health system to cater for an increasing population served by scarce
skilled health professionals. The extent of preparedness of health facilities (primary,
secondary and tertiary) to prevent and manage complications of FGM/C is poorly
understood.

RESEARCH METHODS AND QUESTIONS
A qualitative approach as well as a health facility assessment was undertaken to
understand the health system’s response to the management and prevention of FGM/C
in Imo state. In-depth interviews, focus group discussions, clinical meetings among
service providers, key informant interviews and stakeholder dialogues (national and
state level) were used. A health facility assessment was also conducted to examine
service delivery levels. The study explored how the health system implements the
national policy and plan of action for FGM/C and how the health care sector supports
the prevention and management of FGM/C-related complications to identify possible
solutions for systems strengthening. Descriptive statistics were used to summarise
survey data and qualitative interviews were digitally recorded, transcribed and analysed
using NVIVO 12 software. Thematic analysis was used to explore emergent patterns
and themes within the data. Ethical approval was obtained from Imo State Ministry of
Health and from Population Council’s Institutional Review Board (IRB).
The main questions researchers sought to answer were:
•

How is the health sector responding to existing FGM/C-related laws and policies?

•

What role is the health care sector playing in the prevention of FGM/C?

•

What are contextual stakeholders supporting or
inhibiting the health sector’s response to FGM/C?

•

What is the availability, content, and quality of
FGM/C-related service provision?

•

How is the health sector catering to the needs of
women/girls who have undergone FGM/C?

WHAT THE EVIDENCE SHOWS:
•

•

•

•

•

•

Leadership and governance: Limited political
will and lack of intersectoral collaboration across
different layers of government actors resulted in
poor ownership and implementation of the policies
and action plans related to the elimination of
FGM/C. The role of government in leadership and
coordination of FGM/C activities has been further
limited by funding gaps within the state.
Service readiness: FGM/C awareness and
prevention services were high at the community
level, but the overall level of preparedness of
health facilities to respond to FGM/C related
complications was relatively low as evidenced by
poor infrastructure, lack of equipment and poor
human capacity.

RECOMMENDATIONS
To strengthen the health system response to FGM/C in
Nigeria, we recommend that:
•

There should be improved data management
systems for FGM/C at the facility and community
level to help the government better understand the
levels of FGM/C.

•

The government should demonstrate financial
commitment and ensure transition and ownership of
activities beyond the tenure of FGM/C projects. This
would strengthen the ownership, coordination and
the role of government in the FGM response as well
as improve sustainability of FGM/C programs.

•

Health workers should be properly trained and
sensitized on the WHO guidelines on management
of FGM/C complications to improve their capacity to
respond.

•

Research should be commissioned to explore client
satisfaction, quality of care and management of
FGM/C complications.
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